secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001171843-23-006962
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics Q3 revenue $5.7M (-12% YoY); net loss widens to $2.1M
------------------------------------------------------------------

- Revenue $5.7M vs $6.5M YoY; net loss $(2.1M) or $(0.36)/diluted share vs $(0.02) loss.
- Gross margin improved to 37% from 36%, cost programs partly offset revenue decline.
- Operating expenses up 18% due to legal/settlement fees, CEO transition, and consulting.
- Non-cash tax charge of $0.7M on deferred tax assets deemed unrealizable.
- Restructuring initiated to align costs; new CRO Shannon Shoemaker leading go-to-market changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184323006962/0001171843-23-006962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184323006962/f8k_110923.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-006962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer